The A2 Milk (ASX:A2M) share price was down almost every day in March

The A2 Milk Company Ltd (ASX: A2M) share price has been red for almost every single day in March. Should investors be worried?

| More on:
Glass of milk

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors might want to look away from the A2 Milk Company Ltd (ASX: A2M) share price. Shares in the dairy company have been red for almost every single day since March 4. At the time of writing, the A2 Milk share price is trading at $7.88, up 0.9%.  

How A2 Milk went sour 

After multiple earnings downgrades and rising geopolitical tensions between Australia and China, the A2 Milk share price looks like it has slumped to the point of no return. Its shares are down ~10.6% in March. Additionally, the share price is down ~32% year-to-date. 

Gone are the days where A2 Milk held an Afterpay Ltd (ASX: APT) or CSL Ltd (ASX: CSL) like status. 

Are brokers still positive on A2 Milk? 

Big brokers are still divided on the growth trajectory and recovery path for A2 Milk. There have been two broker notes in March with a diverging buy and sell rating. 

First came the UBS note on 4 March. This retained a buy rating and a NZ$16.00 target price for the dual-listed company. The broker expects a meaningful recovery in indirect infant formula sales in the next two years. In addition, the broker expects substantial market share gains for its China label infant nutrition. The note also highlighted that online brand strength remains strong in China with high WeChat engagement.

The A2 Milk share price is currently fetching NZ$8.61 on the NZX. This represents an upside of 85.8% from the broker's target price. 

The Citi note on 23 March seems to be giving the optimistic UBS a run for its money. The broker retained a sell rating and a $7.15 target price.  

Citi has paid close attention to Feihe – the largest and most highly recognised Chinese infant milk formula company with a reported 17.20% market share in Q3 2020. The broker believes that competition is likely to intensify for foreign infant formula players like A2. It believes the expansion of the market share of Chinese brands is likely to drag A2's growth. The A2 Milk share price would need to fall another 9.50% to reach Citi's target price. 

Commonwealth Bank of Australia (ASX: CBA) reduces its stake 

While brokers might still be divided on where the A2 Milk share price will go next. CBA announced on 23 March that it had reduced its stake in A2 Milk from 46.9 million shares or 6.34% of the company to 39.5 million shares or 5.32%. Luckily for CBA, the A2 Milk share price has slumped another 6% since. 

 

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A diverse group of people form a circle at a park and raise their arms together.
Share Market News

Here are the top 10 ASX 200 shares today

ASX investors ended the trading week on a high note this Friday...

Read more »

Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Catapult, De Grey Mining, Domino's, and Nufarm shares are charging higher

These shares are ending the week strongly. But why?

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Healthcare Shares

This ASX All Ords share is diving 18% as inflation pain draws blood

This healthcare company delivered a trading update at its annual general meeting today.

Read more »

Three analysts look at tech options on a wall screen
Technology Shares

Up 70%, is it too late to invest in Xero shares?

This ASX tech darling hit a new all-time share price record yesterday.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Healius, Opthea, Peninsula Energy, and Wildcat shares are falling today

These shares are having a tough finish to the week. But why?

Read more »

A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
Share Market News

Why this ASX uranium share is plunging 25% on Friday

Let's see why investors are smashing the sell button today.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

How these 3 ASX 200 stocks smashed the benchmark this week

Investors sent these ASX 200 stocks flying higher over the week. But why?

Read more »